National Allergy, Asthma & Urticaria Centers of Charleston, PA — North Charleston, South Carolina

National Allergy, Asthma & Urticaria Centers of Charleston, PA is a clinical research site located in North Charleston, South Carolina, United States 29420-4211.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

National Allergy, Asthma & Urticaria Centers of Charleston, PA has participated in 1 clinical trials.

Therapeutic areas: Primary Immunodeficiency Diseases (PID).

Sponsors: Baxalta now part of Shire.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in North Charleston

Browse all research sites in South Carolina · View every site in North Charleston

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for National Allergy, Asthma & Urticaria Centers of Charleston, PA?

National Allergy, Asthma & Urticaria Centers of Charleston, PA has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has National Allergy, Asthma & Urticaria Centers of Charleston, PA conducted?

National Allergy, Asthma & Urticaria Centers of Charleston, PA has 1 clinical trials on record. Their work covers Primary Immunodeficiency Diseases (PID).

Is National Allergy, Asthma & Urticaria Centers of Charleston, PA accredited by Crixeo Clinical Trials?

National Allergy, Asthma & Urticaria Centers of Charleston, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about National Allergy, Asthma & Urticaria Centers of Charleston, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.